Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies
Authors
Keywords
Monoclonal antibodies to nerve growth factor, Tanezumab, Fulranumab, Osteonecrosis, Rapidly progressive osteoarthritis
Journal
OSTEOARTHRITIS AND CARTILAGE
Volume 23, Issue -, Pages S18-S21
Publisher
Elsevier BV
Online
2014-12-17
DOI
10.1016/j.joca.2014.10.005

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.